BAJAJHCARE Stock Overview
Bajaj HealthCare Limited, a pharmaceutical company, research, develops, manufactures, and supplies amino acids, nutritional supplements, and active pharmaceutical ingredients (APIs) for pharmaceutical, nutraceuticals, and food industries in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 2/6 |
Bajaj HealthCare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹317.65 |
| 52 Week High | ₹513.40 |
| 52 Week Low | ₹275.70 |
| Beta | 0.59 |
| 1 Month Change | 4.68% |
| 3 Month Change | -4.95% |
| 1 Year Change | -1.40% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -12.48% |
Recent News & Updates
Recent updates
Shareholder Returns
| BAJAJHCARE | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 0.4% | -1.4% | -1.6% |
| 1Y | -1.4% | 53.7% | 45.0% |
Return vs Industry: BAJAJHCARE underperformed the Indian Pharmaceuticals industry which returned 53.7% over the past year.
Return vs Market: BAJAJHCARE underperformed the Indian Market which returned 45% over the past year.
Price Volatility
| BAJAJHCARE volatility | |
|---|---|
| BAJAJHCARE Average Weekly Movement | 6.4% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: BAJAJHCARE has not had significant price volatility in the past 3 months.
Volatility Over Time: BAJAJHCARE's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 1,173 | Sajankumar Bajaj | www.bajajhealth.com |
Bajaj HealthCare Limited, a pharmaceutical company, research, develops, manufactures, and supplies amino acids, nutritional supplements, and active pharmaceutical ingredients (APIs) for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company’s product portfolio consists of various APIs in the therapeutic categories of anti-diabetic, antibiotic, antiviral, antiplatelet, antifungal, antihelmintic, iron-chelating agent, anticonvulsant, growth stimulant, non-steroidal anti-inflammatory drugs, antihypertensive, anthelmintics, anti-asthmatic, antioxidant, urinary tract infection, anti-histamine, weight reducing, venous disease, antimalarial, vitamin c, disinfectant/ antiseptic, stimulant, lipotropic agents, nootropic, vasoprotective/ antihemorrhagic, cardiovascular agents, food supplements, anti-anemic, amino acids, antiasthmatic / bronchodilator, nutritional supplement, and minerals. It provides formulations in the form of tablets, capsules, and oral powder, as well as intermediates and impurities.
Bajaj HealthCare Limited Fundamentals Summary
| BAJAJHCARE fundamental statistics | |
|---|---|
| Market cap | ₹8.76b |
| Earnings (TTM) | ₹83.17m |
| Revenue (TTM) | ₹5.21b |
105.3x
P/E Ratio1.7x
P/S RatioIs BAJAJHCARE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BAJAJHCARE income statement (TTM) | |
|---|---|
| Revenue | ₹5.21b |
| Cost of Revenue | ₹3.72b |
| Gross Profit | ₹1.49b |
| Other Expenses | ₹1.41b |
| Earnings | ₹83.17m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.01 |
| Gross Margin | 28.63% |
| Net Profit Margin | 1.60% |
| Debt/Equity Ratio | 112.9% |
How did BAJAJHCARE perform over the long term?
See historical performance and comparison